Instem plc Director/PDMR Shareholding (1972A)

TIDMINS

RNS Number : 1972A

Instem plc

24 May 2019

Instem plc

("Instem" or the "Company")

Director/PDMR Shareholding

Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, was notified on 22 May 2019, that Mike McGoun, a Non-Executive Director of the Company, sold 30,000 ordinary shares of 10p each in the Company ("Ordinary Shares") on 21 May 2019 at a price of 347.55 pence per Ordinary Share.

Following the transaction, Mike now has a total interest in 6,786 Ordinary Shares, representing approximately 0.04% of the Company's issued share capital

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1     Details of the person discharging managerial responsibilities 
        / person closely associated 
 a)    Name                                   Mike McGoun 
      -------------------------------------  ---------------------------------- 
 2     Reason for the notification 
      ------------------------------------------------------------------------- 
 a)    Position/status                        Non Executive Director 
      -------------------------------------  ---------------------------------- 
 b)    Initial notification                   Initial 
        /Amendment 
      -------------------------------------  ---------------------------------- 
 3     Details of the issuer, emission allowance market 
        participant, auction platform, auctioneer or auction 
        monitor 
      ------------------------------------------------------------------------- 
 a)    Name                                   Instem plc 
      -------------------------------------  ---------------------------------- 
 b)    LEI                                    213800PILYUFNNROQX68 
      -------------------------------------  ---------------------------------- 
 4     Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type 
        of transaction; (iii) each date; and (iv) each 
        place where transactions have been conducted 
      ------------------------------------------------------------------------- 
 a)    Description of                         Ordinary shares of 10p each 
        the financial 
        instrument, type 
        of instrument 
 
       Identification                         GB00B3TQCK30 
        code 
 
 b)    Nature of the                          Sale of ordinary shares 
        transaction 
      -------------------------------------  ---------------------------------- 
 c)    Price(s) and volume(s) 
                                              --------------  --------------- 
                                               Price(s)        Volume(s) 
                                              --------------  --------------- 
                                               347.55p         30,000 
                                              --------------  --------------- 
 
 d)    Aggregated information 
 
  - Aggregated volume                    30,000 
 
  - Price                                GBP104,265.00 
 
 e)    Date of the transaction                21 May 2019 
      -------------------------------------  ---------------------------------- 
 f)    Place of the transaction               London Stock Exchange (XLON) 
      -------------------------------------  ----------------------------------

For further information, please contact:

 
 Instem plc                         +44 (0) 1785 825 600 
 Phil Reason, CEO 
 Nigel Goldsmith, CFO 
 
 
   N+1 Singer (Nominated Adviser 
   & Broker)                          +44 (0) 20 7496 3000 
 Richard Lindley 
  Rachel Hayes 
 
 
   Walbrook Financial PR              +44 (0) 20 7933 8780 
 Paul Cornelius                     instem@walbrookpr.com 
 Nick Rome 
  Sam Allen

About Instem

Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.

Instem solutions are in use by customers worldwide and enable our clients to bring life enhancing products to market faster.

Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.

To learn more about Instem solutions and its mission, please visit instem.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBLGDUBGDBGCS

(END) Dow Jones Newswires

May 24, 2019 12:03 ET (16:03 GMT)

Instem (LSE:INS)
Historical Stock Chart
From Jun 2024 to Jul 2024